|
1
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar
|
|
2
|
Kreimer AR, Clifford GM, Boyle P and
Franceschi S: Human papillomavirus types in head and neck squamous
cell carcinomas worldwide: a systematic review. Cancer Epidemiol
Biomarkers Prev. 14:467–475. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lindel K, Beer KT, Laissue J, Greiner RH
and Aebersold DM: Human papillomavirus positive squamous cell
carcinoma of the oropharynx: a radiosensitive subgroup of head and
neck carcinoma. Cancer. 92:805–813. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
D’Souza G, Kreimer AR, Viscidi R, et al:
Case-control study of human papillomavirus and oropharyngeal
cancer. N Engl J Med. 356:1944–1956. 2007.PubMed/NCBI
|
|
5
|
Kumar B, Cordell KG, Lee JS, et al: EGFR,
p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of
response to therapy and survival in oropharyngeal cancer. J Clin
Oncol. 26:3128–3137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Worden FP, Kumar B, Lee JS, et al:
Chemoselection as a strategy for organ preservation in advanced
oropharynx cancer: response and survival positively associated with
HPV16 copy number. J Clin Oncol. 26:3138–3146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Licitra L, Perrone F, Bossi P, et al:
High-risk human papillomavirus affects prognosis in patients with
surgically treated oropharyngeal squamous cell carcinoma. J Clin
Oncol. 24:5630–5636. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Weinberger PM, Yu Z, Haffty BG, et al:
Molecular classification identifies a subset of human
papillomavirus-associated oropharyngeal cancers with favorable
prognosis. J Clin Oncol. 24:736–747. 2006. View Article : Google Scholar
|
|
9
|
Fakhry C, Westra WH, Li S, et al: Improved
survival of patients with human papillomavirus-positive head and
neck squamous cell carcinoma in a prospective clinical trial. J
Natl Cancer Inst. 100:261–269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mizumachi T, Kano S, Sakashita T, et al:
Improved survival of Japanese patients with human
papillomavirus-positive oropharyngeal squamous cell carcinoma. Int
J Clin Oncol. 18:824–828. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Westra WH: The morphologic profile of
HPV-related head and neck squamous carcinoma: implications for
diagnosis, prognosis, and clinical management. Head Neck Pathol.
6(Suppl 1): S48–S54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kalluri R: EMT: when epithelial cells
decide to become mesenchymal-like cells. J Clin Invest.
119:1417–1419. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hashimoto T, Soeno Y, Maeda G, et al:
Progression of oral squamous cell carcinoma accompanied with
reduced E-cadherin expression but not cadherin switch. PLoS One.
7:e478992012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao Z, Ge J, Sun Y, et al: Is E-cadherin
immunoexpression a prognostic factor for head and neck squamous
cell carcinoma (HNSCC)? A systematic review and meta-analysis. Oral
Oncol. 48:761–767. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nishiwaki M, Yamamoto T, Tone S, et al:
Genotyping of human papillomaviruses by a novel one-step typing
method with multiplex PCR and clinical applications. J Clin
Microbiol. 46:1161–1168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Olshan AF, Weissler MC, Pei H, et al:
Alterations of the p16 gene in head and neck cancer: frequency and
association with p53, PRAD-1 and HPV. Oncogene. 14:811–818. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Braakhuis BJ, Snijders PJ, Keune WJ, et
al: Genetic patterns in head and neck cancers that contain or lack
transcriptionally active human papillomavirus. J Natl Cancer Inst.
96:998–1006. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Haraf DJ, Nodzenski E, Brachman D, et al:
Human papilloma virus and p53 in head and neck cancer: clinical
correlates and survival. Clin Cancer Res. 2:755–762.
1996.PubMed/NCBI
|
|
22
|
Perrone F, Suardi S, Pastore E, et al:
Molecular and cytogenetic subgroups of oropharyngeal squamous cell
carcinoma. Clin Cancer Res. 12:6643–6651. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kessis TD, Slebos RJ, Nelson WG, et al:
Human papillomavirus 16 E6 expression disrupts the p53-mediated
cellular response to DNA damage. Proc Natl Acad Sci USA.
90:3988–3992. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Koch WM, Lango M, Sewell D, Zahurak M and
Sidransky D: Head and neck cancer in nonsmokers: a distinct
clinical and molecular entity. Laryngoscope. 109:1544–1551. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nijkamp MM, Span PN, Hoogsteen IJ, van der
Kogel AJ, Kaanders JH and Bussink J: Expression of E-cadherin and
vimentin correlates with metastasis formation in head and neck
squamous cell carcinoma patients. Radiother Oncol. 99:344–348.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Andrews NA, Jones AS, Helliwell TR and
Kinsella AR: Expression of the E-cadherin-catenin cell adhesion
complex in primary squamous cell carcinomas of the head and neck
and their nodal metastases. Br J Cancer. 75:1474–1480. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Baumann JL, Cohen S, Evjen AN, et al:
Human papillomavirus in early laryngeal carcinoma. Laryngoscope.
119:1531–1537. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kreimer AR, Alberg AJ, Daniel R, et al:
Oral human papillomavirus infection in adults is associated with
sexual behavior and HIV serostatus. J Infect Dis. 189:686–698.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Syrjänen S: Human papillomavirus (HPV) in
head and neck cancer. J Clin Virol. 32(Suppl 1): S59–S66. 2005.
|
|
30
|
Vessey CJ, Wilding J, Folarin N, et al:
Altered expression and function of E-cadherin in cervical
intraepithelial neoplasia and invasive squamous cell carcinoma. J
Pathol. 176:151–159. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Matthews K, Leong CM, Baxter L, et al:
Depletion of Langerhans cells in human papillomavirus type
16-infected skin is associated with E6-mediated down regulation of
E-cadherin. J Virol. 77:8378–8385. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jung YS, Kato I and Kim HR: A novel
function of HPV16-E6/E7 in epithelial-mesenchymal transition.
Biochem Biophys Res Commun. 435:339–344. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gerlinger M, Rowan AJ, Horswell S, et al:
Intratumor heterogeneity and branched evolution revealed by
multiregion sequencing. N Engl J Med. 366:883–892. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mroz EA and Rocco JW: MATH, a novel
measure of intratumor genetic heterogeneity, is high in
poor-outcome classes of head and neck squamous cell carcinoma. Oral
Oncol. 49:211–215. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mroz EA and Rocco JW: Gene expression
analysis as a tool in early-stage oral cancer management. J Clin
Oncol. 30:4053–4055. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
